Hudson Valley Disability Hearings Return to West Nyack—But Long Wait Times and denials may Loom for New SSDI Applicants
After a five-month gap, the Social Security Administration will reopen disability hearings in West Nyack, NY, restoring access for Hudson Valley residents. The new hearing office begins sessions November 17, 2025, helping thousands waiting on appeals after the closure of White Plains. But while that’s welcome news for current appellants, new SSDI applicants still face 230+ day waits, record denial rates, and growing backlogs across the country. Our latest report breaks down what this reopening really means—and what applicants should expect heading into 2026.
When the Immune System’s “Gloves” Slip: New Clues About Long-Term Illness after infection and Long Covid
A 2025 Nature study offers a simple but powerful idea: some immune systems have “slippery gloves” that can’t fully clear infection leftovers, possibly explaining lasting symptoms like fatigue and brain fog after Covid or Lyme Disease. Here’s what that means for patients and SSDI documentation.
Stem Cell Breakthrough May Help the Brain Heal Itself After Stroke
New research from the University of Zurich shows that human stem cells made from ordinary adult cells can repair stroke damage in the brain — restoring movement and rebuilding lost tissue in mice. The discovery could one day help millions of stroke survivors regain what was once thought lost forever.
Long COVID Brain Fog Is Real — Scientists Identify Its Biological Cause
Scientists have confirmed that Long COVID brain fog is real — and they’ve discovered its biological cause. The breakthrough offers new hope for diagnosis and treatment.
Cancer Rates Are Rising Among Young Adults: What This Means for SSDI Claims
Cancer is rising in young adults at alarming rates—and with it, the challenge of winning SSDI claims before age 50. Learn which cancers qualify under SSA’s Blue Book, how Compassionate Allowances fast-track severe cases, and how to examine your disability claim.
Hope for Breast Cancer Survivors: New Study Shows Path to Preventing Recurrence
A breakthrough clinical trial from Penn Medicine has shown that repurposed drugs can eliminate dormant breast cancer cells—the very cells that cause recurrence years later. For survivors, this means real hope. For those with stage 4 breast cancer, it deepens understanding of why cancers return and may open doors to better treatments. Learn how this ties into SSDI eligibility, Compassionate Allowances, and the future of survivorship.
Social Security Expands Compassionate Allowances: 13 New Conditions Added for Faster SSDI Decisions
The Social Security Administration has expanded its Compassionate Allowances list by adding 13 new medical conditions, bringing the total to 300. This update could mean faster SSDI approvals for individuals facing severe and rare diagnoses. Learn what’s changed and how it may affect your disability claim.
Thymic Carcinoma Now on SSA’s Compassionate Allowance List—And a New Treatment Offers Hope
Thymic carcinoma is now part of SSA's Compassionate Allowances list, meaning faster SSDI access for patients with this rare, aggressive cancer. Learn how new treatments and CAL status can impact your claim.
A Single Protein Just Rejuvenated Memory in Old Mice—Here’s Why That’s Hopeful for Alzheimer’s
Scientists identified a single protein, FTL1, that acts like a dimmer switch on aging neurons. Dialing it down in old mice enhanced memory bridges, hinting at a future therapy relevant to Alzheimer’s—though human trials are still ahead.
AI Is Transforming Cancer Care: Breakthroughs, Hope, and How You Can Benefit
AI is transforming cancer care and bringing faster diagnoses, earlier detection, and personalized treatments that were once unimaginable. From AI-powered blood tests to precision oncology and smarter clinical trials, discover how these breakthroughs are changing outcomes and what you can do to benefit from them right now.
AI and SSDI: The Promise and Perils of Artificial Intelligence in Disability Decisions
Explore the balanced pros and cons of SSA’s AI tool Insight—which speeds up SSDI decision-making and improves consistency, but also risks bias without strong oversight.